156 related articles for article (PubMed ID: 17512076)
1. Influence of fillers in powder formulations containing N-acetyl-L-cysteine on nasal peptide absorption.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2007 Jul; 120(1-2):88-94. PubMed ID: 17512076
[TBL] [Abstract][Full Text] [Related]
2. Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2006 Oct; 115(2):183-8. PubMed ID: 16989920
[TBL] [Abstract][Full Text] [Related]
3. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
4. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
[TBL] [Abstract][Full Text] [Related]
5. Nasal Drug Absorption from Powder Formulations: Effect of Fluid Volume Changes on the Mucosal Surface.
Tanaka A; Furubayashi T; Enomura Y; Hori T; Shimomura R; Maeda C; Kimura S; Inoue D; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2017; 40(2):212-219. PubMed ID: 28154262
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2006 Jan; 110(2):347-352. PubMed ID: 16274829
[TBL] [Abstract][Full Text] [Related]
7. Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC).
Tanaka A; Furubayashi T; Tomisaki M; Kawakami M; Kimura S; Inoue D; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Sci; 2017 Jan; 96():284-289. PubMed ID: 27664332
[TBL] [Abstract][Full Text] [Related]
8. [Optimization of Nasal Drug Absorption from Powder Formulations: The Feasibility of Controlling Drug Absorption by the Use of Pharmaceutical Excipients].
Tanaka A
Yakugaku Zasshi; 2018; 138(12):1467-1472. PubMed ID: 30504659
[TBL] [Abstract][Full Text] [Related]
9. The Enhancement of Nasal Drug Absorption From Powder Formulations by the Addition of Sodium Carboxymethyl Cellulose.
Tanaka A; Furubayashi T; Yamasaki H; Takano K; Kawakami M; Kimura S; Inoue D; Katsumi H; Sakane T; Yamamoto A
IEEE Trans Nanobioscience; 2016 Dec; 15(8):798-803. PubMed ID: 28060709
[TBL] [Abstract][Full Text] [Related]
10. Improved nasal bioavailability of elcatonin by insoluble powder formulation.
Ishikawa F; Katsura M; Tamai I; Tsuji A
Int J Pharm; 2001 Aug; 224(1-2):105-14. PubMed ID: 11472819
[TBL] [Abstract][Full Text] [Related]
11. Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside.
Arnold JJ; Fyrberg MD; Meezan E; Pillion DJ
J Pharm Sci; 2010 Apr; 99(4):1912-20. PubMed ID: 19894270
[TBL] [Abstract][Full Text] [Related]
12. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery.
Chen SC; Eiting K; Cui K; Leonard AK; Morris D; Li CY; Farber K; Sileno AP; Houston ME; Johnson PH; Quay SC; Costantino HR
J Pharm Sci; 2006 Jun; 95(6):1364-71. PubMed ID: 16625659
[TBL] [Abstract][Full Text] [Related]
14. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
Lee WA; Narog BA; Patapoff TW; Wang YJ
J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
[TBL] [Abstract][Full Text] [Related]
15. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
16. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Hinchcliffe M; Jabbal-Gill I; Smith A
J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
[TBL] [Abstract][Full Text] [Related]
17. Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption.
Tanaka A; Furubayashi T; Matsushita A; Inoue D; Kimura S; Katsumi H; Sakane T; Yamamoto A
PLoS One; 2016; 11(9):e0159150. PubMed ID: 27598527
[TBL] [Abstract][Full Text] [Related]
18. Opportunity and challenges of nasal powders: Drug formulation and delivery.
Tiozzo Fasiolo L; Manniello MD; Tratta E; Buttini F; Rossi A; Sonvico F; Bortolotti F; Russo P; Colombo G
Eur J Pharm Sci; 2018 Feb; 113():2-17. PubMed ID: 28942007
[TBL] [Abstract][Full Text] [Related]
19. Insoluble powder formulation as an effective nasal drug delivery system.
Ishikawa F; Murano M; Hiraishi M; Yamaguchi T; Tamai I; Tsuji A
Pharm Res; 2002 Aug; 19(8):1097-104. PubMed ID: 12240934
[TBL] [Abstract][Full Text] [Related]
20. Development and
Wang D; Du Y; Zhang W; Han X; Zhang H; Wang Z; Liu N; Li M; Gao X; Zhuang X; Gao J; Zheng A
Drug Deliv; 2021 Dec; 28(1):487-498. PubMed ID: 33657948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
